Medina Colic

Medina Colic

Auto-generated profile, based on publicly available information

Medina Colic

Department of Bioinformatics and Computational Biology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
6 February 2023 in Nature Cell Biology
Verified
Journal Article
Closed access
PDF file
XLXiaoguang Liu
Xiaoguang Liu
LNLitong Nie
Litong Nie
YZYilei Zhang
Yilei Zhang
YYYuelong Yan
Yuelong Yan
CWChao Wang
Chao Wang
BGBoyi Gan
Boyi Gan

22 August 2019 in Genome Medicine
Verified
Journal Article
Open access
PDF file
MCMedina Colic
Medina Colic
GWGang Wang
Gang Wang
MZMichal Zimmermann
Michal Zimmermann
KMKeith Mascall
Keith Mascall
MMMegan McLaughlin
Megan McLaughlin
THTraver Hart
Traver Hart
Chemogenetic profiling enables the identification of gene mutations that enhance or suppress the activity of chemical compounds. This knowledge provides insights into drug mechanism of action, genetic vulnerabilities, and resistance mechanisms, all of which may help stratify patient populations and improve drug efficacy. CRISPR-based screening enables sensitive detection of drug-gene interactions directly in human cells, but until recently has primarily been used to screen only for resistance mechanisms. We present drugZ, an algorithm for identifying both synergistic and suppressor chemogenetic interactions from CRISPR screens. DrugZ identifies synthetic lethal interactions between PARP inhibitors and both known and novel members of the DNA damage repair pathway, confirms KEAP1 loss as a resistance factor for ERK inhibitors in oncogenic KRAS backgrounds, and defines the genetic context for temozolomide activity. DrugZ is an open-source Python software for the analysis of genome-scale drug modifier screens. The software accurately identifies genetic perturbations that enhance or suppress drug activity. Interestingly, analysis of new and previously published data reveals tumor suppressor genes are drug-agnostic resistance genes in drug modifier screens. The software is available at github.com/hart-lab/drugz .

1 April 2020 in Neuron
Verified
Journal Article
Closed access
MWMary H. Wertz
Mary H. Wertz
MMMollie R. Mitchem
Mollie R. Mitchem
SPS. Sebastian Pineda
S. Sebastian Pineda
LHLea J. Hachigian
Lea J. Hachigian
HLHyeseung Lee
Hyeseung Lee
MHMyriam Heiman
Myriam Heiman

12 April 2019 in Life Science Alliance
Verified
Journal Article
Open access
PDF file
EKEiru Kim
Eiru Kim
MDMerve Dede
Merve Dede
WLWalter F Lenoir
Walter F Lenoir
GWGang Wang
Gang Wang
SSSanjana Srinivasan
Sanjana Srinivasan
THTraver Hart
Traver Hart
Genetic interactions mediate the emergence of phenotype from genotype. The systematic survey of genetic interactions in yeast showed that genes operating in the same biological process have highly correlated genetic interaction profiles, and this observation has been exploited to infer gene function in model organisms. Such assays of digenic perturbations in human cells are also highly informative, but are not scalable, even with CRISPR-mediated methods. As an alternative, we developed an indirect method of deriving functional interactions. We show that genes having correlated knockout fitness profiles across diverse, non-isogenic cell lines are analogous to genes having correlated genetic interaction profiles across isogenic query strains and similarly imply shared biological function. We constructed a network of genes with correlated fitness profiles across 276 high-quality CRISPR knockout screens in cancer cell lines into a “coessentiality network,” with up to 500-fold enrichment for co-functional gene pairs, enabling strong inference of gene function and highlighting the modular organization of the cell.

1 March 2020 in DNA Repair
Verified
Journal Article
Closed access
DSDan Su
Dan Su
XFXu Feng
Xu Feng
MCMedina Colic
Medina Colic
YWYunfei Wang
Yunfei Wang
CZChunchao Zhang
Chunchao Zhang
JCJunjie Chen
Junjie Chen

11 November 2021 in Nature Communications
Verified
Journal Article
Open access
PDF file
WLW. Frank Lenoir
W. Frank Lenoir
MMMicaela Morgado
Micaela Morgado
PDPeter C. DeWeirdt
Peter C. DeWeirdt
MMMegan McLaughlin
Megan McLaughlin
AGAudrey L. Griffith
Audrey L. Griffith
THTraver Hart
Traver Hart
CRISPR knockout fitness screens in cancer cell lines reveal many genes whose loss of function causes cell death or loss of fitness or, more rarely, the opposite phenotype of faster proliferation. Here we demonstrate a systematic approach to identify these proliferation suppressors, which are highly enriched for tumor suppressor genes, and define a network of 145 such genes in 22 modules. One module contains several elements of the glycerolipid biosynthesis pathway and operates exclusively in a subset of acute myeloid leukemia cell lines. The proliferation suppressor activity of genes involved in the synthesis of saturated fatty acids, coupled with a more severe loss of fitness phenotype for genes in the desaturation pathway, suggests that these cells operate at the limit of their carrying capacity for saturated fatty acids, which we confirm biochemically. Overexpression of this module is associated with a survival advantage in juvenile leukemias, suggesting a clinically relevant subtype.